Prizloncabtagene Autoleucel
0702-025
Phase 1 mab active
Quick answer
Prizloncabtagene Autoleucel for Non-Hodgkin's B-cell Lymphoma is a Phase 1 program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Non-Hodgkin's B-cell Lymphoma
- Phase
- Phase 1
- Modality
- mab
- Status
- active